Open Access
Med Buccale Chir Buccale
Volume 22, Number 4, Décembre 2016
Page(s) 325 - 330
Section Cas clinique et revue de la littérature / Up-to date review and case report
Published online 21 December 2016
  1. Abdulrahman A, Mahmood S, Al-Shakhs M, Al-Suhaim F. An unusual case of atrophic mandible fracture in a patient with osteogenesis imperfecta and on oral bisphosphonate therapy: Case report. Saudi Dent J 2014;26:68-73. [CrossRef] [PubMed] [Google Scholar]
  2. Wallace DJ, Chau FY, Santiago-Turla C, Hauser M, Challa P, Lee PP, et al. Osteogenesis imperfecta and primary open angle glaucoma: Genotypic analysis of a new phenotypic association. Mol Vis 2014;20:1174-1181. [PubMed] [Google Scholar]
  3. Dogba M, Rauch F, Wong T, Ruck J, Glorieux F, Bedos C. From pediatric to adult care: strategic evaluation of a transition program for patients with osteogenesis imperfecta. BMC Health Serv Res 2014;14:489. [CrossRef] [PubMed] [Google Scholar]
  4. Edelu B, Ndu I, Asinobi I, Obu H, Adimora G. Osteogenesis Imperfecta: A Case Report and Review of Literature. Ann Med Health Sci Res 2014;4(Suppl 1):S1-S5. [CrossRef] [PubMed] [Google Scholar]
  5. Eugênia R. What is new in genetics and osteogenesis imperfecta classification? .jped.2014.05.003 [Google Scholar]
  6. Tosi L, Oetgen M, Floor M, Huber M, Kennelly A, McCarter RJ, et al. Initial report of the osteogenesis imperfecta adult natural history initiative. Orphanet J Rare Dis 2015;10:146. [CrossRef] [PubMed] [Google Scholar]
  7. Caouette C, Rauch F, Villemure I, Arnoux P, Gdalevitch M, Veilleux LN, et al. Biomechanical analysis of fracture risk associated with tibia deformity in children with osteogenesis imperfecta: a finite element analysis. Musculoskelet Neuronal Interact 2014;14:205-212. [Google Scholar]
  8. Jagtap SR, Bakhshi RG, Jain A. A rare occurrence of pyloric stenosis in an infant with osteogenesis imperfecta: Anesthetic implications. J Anaesthesiol Clin Pharmacol 2014; 30:270-272. [CrossRef] [PubMed] [Google Scholar]
  9. Grafe I, Yang T, Alexander S, Homan EP, Lietman C, Jiang MM, et al. Excessive TGFβ signaling is a common mechanism in Osteogenesis Imperfecta. Nat Med 2014;670-675. [Google Scholar]
  10. Abukabbosa H, Al-Sineedib F. Clinical manifestations and dental management of dentinogenesis imperfecta associated with osteogenesis imperfecta: Case report. Saudi Dent J 2013;25: 159-165. [CrossRef] [PubMed] [Google Scholar]
  11. Boyce AL, Tosi LM, Paul SM. Bisphosphonate treatment for children with disabling conditions. PMR 2014;6:427-436. [Google Scholar]
  12. Georgescu I, Vlad C, Gavriliu TS, Dan S, Pârvan AA. Surgical treatment in Osteogenesis imperfecta – 10 years experience. J Med Life 2013;6(2):205-213. [PubMed] [Google Scholar]
  13. Van Dijk FS, Cobben JM, Kariminejad A, Maugeri A, Nikkels PG, van Rijn RR, et al. Osteogenesis Imperfecta: A Review with Clinical Examples. Mol Syndromol 2011;2:1-20. [EDP Sciences] [PubMed] [Google Scholar]
  14. Hennedige AA, Jayasinghe J, Khajeh J, Macfarlane TV. Systematic review on the incidence of bisphosphonate related osteonecrosis of the jaw in children diagnosed with osteogenesis imperfecta. J Oral Maxillofac Res 2014;4:e1. [PubMed] [Google Scholar]
  15. Maines E, Monti E, Doro F, Morandi G, Cavarzere P, Antoniazzi F. Children and adolescents treated with neridronate for osteogenesis imperfecta show no evidence of any osteonecrosis of the jaw. J Bone Miner Metab 2012;30:434-438. [CrossRef] [PubMed] [Google Scholar]
  16. Fedele S, Kumar N, Davies R, Fiske J, Greening S, Porter S. Dental management of patients at risk of osteochemonecrosis of the jaws: a critical review. Oral Dis 2009;15:527-537. [CrossRef] [PubMed] [Google Scholar]
  17. Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Clin Ther 2007; 29:1548-1558. [CrossRef] [PubMed] [Google Scholar]
  18. Beninati F, Pruneti R, Ficarra G. Bisphosphonate-related osteonecrosis of the jaws. Med Oral Patol Oral Cir Bucal 2013;18:752-758. [CrossRef] [Google Scholar]
  19. Brown J, Ramalingam L, Zacharin MR. Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children? Clin Endocrinol 2008;68:863-867. [CrossRef] [Google Scholar]
  20. Chahine C, Cheung MS, Head TW, Schwartz S, Glorieux FH, Rauch F. Tooth extraction socket healing in pediatric patients treated with intravenous pamidronate. J Pediatr 2008;153:719-720. [CrossRef] [PubMed] [Google Scholar]
  21. Ezra A, Golomb G. Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption. Adv Drug Deliv Rev 2000;42:175-195. [CrossRef] [PubMed] [Google Scholar]
  22. Drake MT, Clarke BL, Khosla S. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc 2008; 83(9):1032-1045. [CrossRef] [PubMed] [Google Scholar]
  23. Lin H. Bisphosphonates: a review of their pharmacokinetic properties. Bone 1996;18:75-85. [CrossRef] [PubMed] [Google Scholar]
  24. Marx R, Cillo J, Ulloa J. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 2007;65:2397-2410. [CrossRef] [PubMed] [Google Scholar]
  25. Olutayo J, Agbaje JO, Jacobs R, Verhaeghe V, Velde FV, Vinckier F. Bisphosphonate-Related Osteonecrosis of the Jaw Bone: Radiological Pattern and the Potential Role of CBCT in Early Diagnosis. J Oral Maxillofac Res 2010;1:3. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.